Apart from being the CEO, Marc Beer is also the chairman and co-founder of Renovia Inc. Marc Beer is an experienced manager having twenty-five years specializing in commercialization and development in both pharmaceutical, diagnostic and device industries.
Marc Beer was the former Avegerion pharmaceuticals CEO. After leaving Aegerion where he had worked for five years, Renovia Inc. was his first venture. Marc Beer stated that he thought of the company after meeting Dr. Ray Iglesias. Dr. Ray is a gynecologist who had done pelvic floor surgeries for the last thirty years.
He had spent the last seven to ten years discovering how he could help women with pelvic disorders without using surgery. It was then that Marc Beer decided he had found the right person to think about innovation to develop products to keep women with pelvic disorders from going through unnecessary surgeries.
Renovia Inc. was formed to create new products for pelvic floor disorders. According to researchers, pelvic disorders affect nearly two fifty million worldwide. Marc beer renovia is a medtech company that is focused on creating and developing different diagnostic as well as therapeutic products to heal pelvic floor disorders. Urinary incontinence is an example of and a common pelvic floor disorder.
The first product that Marc Beer Renovia created to battle with pelvic disorders was Leva which received FDA approval back in April 2018. Leva has gone on to attract funding for its further development. Longwood fund which is an investment firm that is focused on health care investments had invested in Leva’s early production and trials.
The firm has decided to further invest in the series b round. The series B round will be headed by perspective advisors from New York and Ascension Ventures who are based in Missouri. The funding that Marc Beer Renovia will receive will be used to develop and test four more rounds of therapeutic and diagnostic products which will include a new generation of leva. The series B managed to get $32 million and $10 million regarding venture debt.
Mr. Marc Beer said that he was very excited to have the support of leading health care investors who share the same goal and vision as him of having better diagnosis and treatment methods so that they can improve the lives of women affected by pelvic disorders.
He added that he was confident that by combining his’ firms innovative and sensor technology and forming a digital health platform they would be able to give customers important information regarding new treatment options. By doing this, they will also improve the understanding and knowledge that people have on pelvic disorders and lower health care costs. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer